Previous 10 | Next 10 |
United Therapeutics Announces Agreement To Acquire Priority Review Voucher Voucher expected to be applied to the forthcoming NDA for Tyvaso DPI™ PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Dec. 28, 2020 /PRNewswire/ -- Un...
The FDA has granted orphan drug designation to United Therapeutics' (UTHR) treprostinil for the treatment of patients with idiopathic pulmonary fibrosis ((IPF)).The company intends to initiate a Phase 3 study, called TETON, to evaluate the use of Tyvaso (treprostinil) Inhalation Solution...
United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Dec. 9, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced to...
United Therapeutics Releases Its First Corporate Responsibility Report Report available at corporateresponsibility.unither.com PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Nov. 24, 2020 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C....
MannKind (MNKD) has achieved the final development milestone under its licensing agreement with United Therapeutics (UTHR) for the development and commercialization of a dry powder formulation of treprostinil. Treprostinil Technosphere (TreT) is being evaluated for the treatment of ...
BioMarin is a leader in rare disease therapy discovery with multiple competitive advantages including scale, expertise, patents and relationships. Two major catalysts for 2021 provide investors with favorable risk/reward skew afforded by a low share price that should not be ignored. ...
Acceleron Pharma ([[XLRN]] -1.8%) announces new data from two Phase 2 clinical trials, SPECTRA and PULSAR, evaluating sotatercept in patients with pulmonary arterial hypertension ((PAH)).Preliminary results from 10 participants in SPECTRA showed that treated patients experienced substantial i...
As Pfizer (PFE) announced that its COVID-19 vaccine candidate is 90% effective, biotech stocks are on fire. These stocks have seen a bull-run since the beginning of 2020 and are expected to witness the same in 2021 as well. In addition to the boost from the pandemic, Jazz (JAZZ), Arrowhead (A...
United Therapeutics Corporation To Present At The Jefferies Virtual London Healthcare Conference PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2020 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Nov. 10, 2020 /PRNewswire...
The recent unsolicited licensing offer is likely United Therapeutics, which has several compelling reasons to want to own Liquidia and could pay a large premium to block the RareGen merger. If a near term deal with United Therapeutics does not come to fruition (it would have to occur ...
News, Short Squeeze, Breakout and More Instantly...
United Therapeutics Corporation Company Name:
UTHR Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation Website:
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
2024-07-11 06:30:06 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for UTHR on July 11, 2024 04:53AM ET. The previous analyst recommendation was Overweight. UTHR was trading at $329.25 at issue of the analyst recommendation. The overall analyst consensus : ...
Over 100,000 patients in the United States have IPF, with two approved therapies available that only slow the course of disease progression Top line data expected in the second half of 2025 United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announ...